Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Cancer shared this article with you from Inoreader Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas Via MedWorm Cancer & Oncology Clinical Trials Conditions:   Chemotherapy;   Anti-pd-1 Antibody;   Cervical Neuroendocrine Carcinoma;   Adverse Drug Event;   Recurrent Cervical Carcinoma;   Advanced Cervical Carcinoma;   Objective Response Rate Intervention:   Drug: Drug therapy Sponsor:   Lei Li Recruiting (Source: ClinicalTrials.gov) View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.